Sign in
4

Changes in Ownership

BIO-TECHNE Corp Filed Acc 0001062993-23-015315

Chief Executive Officer sold 80,000 shares at $88.36 ($7,069,024)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Kummeth Charles R. Chief Executive Officer 2023-07-21 Sale 10b5-1 −80,000 $88.36 $7,069,024 1,258,766 D
Open-market sales · 80,000 sh · avg $88.36 · $7,069,024
Loading xslF345X05/form4.xml…